Canntab enters $1M purchase agreement with MediPharm

Mugglehead
By Nick LabaJun 2, 2020, 5:50 pm273 pts
Canadian biopharmaceutical company Canntab Therapeutics Limited (CSE: PILL.CN) is starting to produce and sell its proprietary medical cannabis tablets. In a statement Tuesday, Canntab said it’s beginning production of its instant release tablets and has entered into its first purchase agreement with…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

US House Committee Approves Bill to Close THCA ‘Loophole,’ Ban Intoxicating Hemp Products 48

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.